9th Circ. Gives Allergan 2nd Chance To Ax FCA Suit
The Ninth Circuit has reversed a lower court decision that shut down pharmaceutical giant Allergan's bid to toss a patent attorney's whistleblower suit over dementia drug patents, determining Thursday that the...To view the full article, register now.
Already a subscriber? Click here to view full article